Plus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Plus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Plus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Plus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Plus Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4259170A1 | Application | Pharmaceutical composition for use in prevention and treatment of liver fibrosis and/or liver cirrhosis, comprising adipose-derived regenerative cells (ADRCS) | A61K35/35; A61P1/16 | October 18, 2023 |
| EP4247345A1 | Application | Radioaktiv markierte liposome und verfahren zur verwendung davon | A61K51/12; A61K31/191; A61K51/1234; A61K2300/00; A61K9/0019; A61K9/127; A61K31/198; A61K31/401; C07F13/00; A61K31/555; A61K51/0478; C07F13/005 | September 27, 2023 |
| WO2023146931A3 | Application | Radiolabeled liposomes and methods of use for treating leptomeningeal metastases | A61K51/1234; A61K9/0019; A61K9/127; A61P35/04 | September 07, 2023 |
| WO2023146931A2 | Application | Radiolabeled liposomes and methods of use for treating leptomeningeal metastases | A61K51/1234; A61K9/0019; A61K9/127; A61P35/04 | August 03, 2023 |
| IL302964A | Application | Radiolabeled liposomes and methods of use thereof | A61K31/191; A61K31/401; A61K51/0478; A61K31/198; A61K31/555; A61K51/12; C07F13/005; A61K2300/00; A61K9/127; C07F13/00; A61K51/1234; A61K9/0019 | July 01, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer